Tumor News and Research

RSS
ScreenIn3D receives technology innovation prize

ScreenIn3D receives technology innovation prize

Adult survivors of pediatric brain tumors may experience cognitive, socioeconomic burdens

Adult survivors of pediatric brain tumors may experience cognitive, socioeconomic burdens

Non-classical monocytes directly involved in regulation of immune response

Non-classical monocytes directly involved in regulation of immune response

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

MSK receives approval for new molecular assay from New York State Department of Health

MSK receives approval for new molecular assay from New York State Department of Health

Elite group of immune cells plays key role in fighting tumors

Elite group of immune cells plays key role in fighting tumors

Study calls for more aggressive treatments to improve 5-year survival in glioblastoma patients

Study calls for more aggressive treatments to improve 5-year survival in glioblastoma patients

Study reveals genetic signature of failed immune response to cancer

Study reveals genetic signature of failed immune response to cancer

UVA launches Fibrosis Initiative to fight the growing cause of death

UVA launches Fibrosis Initiative to fight the growing cause of death

New study points out simple problem with existing model of cancer

New study points out simple problem with existing model of cancer

Timed release of curcumin inhibits cancer cell growth

Timed release of curcumin inhibits cancer cell growth

Surgeons’ opioid-prescribing habits hard to kick

Surgeons’ opioid-prescribing habits hard to kick

More insights into transport protein used by cancer cells

More insights into transport protein used by cancer cells

Researchers report new way for creating tracers used with medical imaging

Researchers report new way for creating tracers used with medical imaging

Study emphasizes need for more aggressive treatments for glioblastoma patients

Study emphasizes need for more aggressive treatments for glioblastoma patients

UT Dallas adds MILabs Hybrid OI/CT system to its innovative medical imaging solutions

UT Dallas adds MILabs Hybrid OI/CT system to its innovative medical imaging solutions

Men who eat yogurt twice a week are less likely to develop bowel cancer

Men who eat yogurt twice a week are less likely to develop bowel cancer

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Novel microfluidic device captures and isolates circulating tumor cell clusters

Novel microfluidic device captures and isolates circulating tumor cell clusters

Novel approach of blocking inflammation before surgical procedure may prevent cancer recurrences

Novel approach of blocking inflammation before surgical procedure may prevent cancer recurrences